NeuroBlade Funding: $110M Raised, Series B (2024)

NeuroBlade is based in Tel Aviv, Israel. It has raised $110M in total funding. Latest round: Series B.

NeuroBlade funding overview

NeuroBlade is based in Tel Aviv, Israel. NeuroBlade has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2024. The round record for NeuroBlade runs through 2024; nothing later has been disclosed. Investors on record include Corner Ventures, Intel Capital, Grove Ventures, StageOne Ventures, Marius Nacht, MediaTek and 4 others. 10 distinct backers are named across the disclosed rounds.

NeuroBlade at a glance

Total raised
$110M
Latest round
Series B
Latest round date
June 2024
Headquarters
Tel Aviv, Israel
Notable investors
Corner Ventures, Intel Capital, Grove Ventures, StageOne Ventures, Marius Nacht, MediaTek, Pegatron, PSMC

Frequently asked about NeuroBlade funding

How much has NeuroBlade raised?
NeuroBlade has raised $110M in total disclosed funding across the rounds on record.
Who has invested in NeuroBlade?
Corner Ventures, Intel Capital, Grove Ventures, StageOne Ventures, Marius Nacht, MediaTek are named among the investors backing NeuroBlade.
What was the latest NeuroBlade funding round?
The most recent disclosed round is a Series B, announced in June 2024.
Where is NeuroBlade based?
NeuroBlade is based in Tel Aviv, Israel.
When did NeuroBlade last raise?
The last disclosed NeuroBlade round closed in June 2024 at Series B.

NeuroBlade totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Tel Aviv below to benchmark round size and investor mix.

Companies related to NeuroBlade (29)

Browse related funding lists (9)

Company funding database · Investor directory · Founder database · Mega-rounds 2026